FREE Account Opening + No Clearing Fees
August 30, 2019 - September 4, 2019

Smiloshine IPO Review & Recommendations

Dilip Davda recommend to "Avoid" the IPO.

Smiloshine IPO Review Summary from brokers and analysts

Review By Apply May Apply Neutral Avoid Not Rated
Count 0 0 0 1 0
% 0.00 0.00 0.00 100.00 0.00

Smiloshine IPO Analysis By Brokers/Analysts

Reviewer Recommendation Past Reviews
Dilip Davda Avoid

Smiloshine IPO Review by Dilip Davda (Avoid)

[Dilip Davda]  Financial data does not merit the exorbitant asking price. LM has a poor track record. There is no harm in giving this issue a miss. Read detail review...

Post Recommendation Manage Recommendations


  • The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of or its staff.
  • We reserve the right to remove any objectionable post without providing a reason.